Auteur M. HILLHOUSE

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Childhood adverse events and methamphetamine use among men and women

N. MESSINA ; P. MARINELLI-CASEY ; M. HILLHOUSE ; R. RAWSON ; J. HUNTER ; A. ANG | 2008
Dans Journal of Psychoactive Drugs (n°SARC Suppl.5, 2008) Article : Périodique

ENGLISH : Women report extensive histories of childhood abuse, often leading to addiction. Studies assessing the same effects for men are lacking. This study describes childhood adverse events (CAEs) among methamphetamine (MA)-dependent men an[...]

Plus d'info

Ajouter à la sélection

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology

L. J. MOONEY ; S. NIELSEN ; A. SAXON ; M. HILLHOUSE ; C. THOMAS ; A. HASSON ; D. STABLEIN ; J. McCORMACK ; R. LINDBLAD ; W. LING | 2013
Dans Contemporary Clinical Trials (Vol.34, n°2, March 2013) Article : Périodique

BACKGROUND: Effective medications to treat cocaine dependence have not been identified. Recent pharmacotherapy trials demonstrate the potential efficacy of buprenorphine (BUP) (alone or with naltrexone) for reducing cocaine use. The National Ins[...]

Plus d'info

Ajouter à la sélection

Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial

S. E. BACK ; R. L. PAYNE ; A. H. WAHLQUIST ; R. E. CARTER ; Z. STROUD ; L. HAYNES ; M. HILLHOUSE ; K. T. BRADY ; W. LING | 2011
Dans American Journal of Drug and Alcohol Abuse (Vol.37, n°5, 2011) Article : Périodique

Background: Accumulating evidence indicates important gender differences in substance use disorders. Little is known, however, about gender differences and opioid use disorders. Objectives: To compare demographic characteristics, substance use s[...]

Plus d'info

Ajouter à la sélection

Lien externe

From research to the real world: Buprenorphine in the decade of the Clinical Trials Network

W. LING ; P. JACOBS ; M. HILLHOUSE ; A. HASSON ; C. THOMAS ; T. FREESE ; S. SPARENBORG ; D. McCARTY ; R. WEISS ; A. SAXON ; A. COHEN ; M. STRAUS ; G. BRIGHAM ; D. LIU ; P. McLAUGHLIN ; B. TAI | 2010
Dans Journal of Substance Abuse Treatment (Vol.38, Suppl.1, June 2010) Article : Périodique

The National Institute on Drug Abuse (NIDA) established the National Drug Abuse Treatment Clinical Trials Network (CTN) in 1999 to bring researchers and treatment providers together to develop a clinically relevant research agenda. Initial CTN e[...]

Plus d'info

Ajouter à la sélection

Hepatitis A and B infection among methamphetamine-dependent users

R. GONZALES ; P. MARINELLI-CASEY ; M. HILLHOUSE ; J. HUNTER ; R. A. RAWSON ; L. MOONEY ; A. ANG | 2008
Périodique

ENGLISH : Epidemiological trends of hepatitis infections among methamphetamine (MA)-dependent individuals are important public health and policy issues. The burden of such infections among MA-dependent users has not been widely studied. This l[...]

Plus d'info

Ajouter à la sélection

A multi-center randomized trial of buprenorphinenaloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network

W. LING ; L. AMASS ; S. SHOPTAW ; J. J. ANNON ; M. HILLHOUSE ; D. BABCOCK ; BRIGHMA G. ; J. HARRER ; M. REID ; MUIR J. ; BUCHAN B. ; ORR D. ; G. WOODY ; J. KREJCI ; D. ZIEDONIS ; Buprenorphine Study Protocol Group | 2005
Périodique

FRANÇAIS : L'étude a porté sur 113 patients hospitalisés (77 sous buprénorphine-naloxone, 36 sous clonidine) et 231 patients en traitement ambulatoire (157 sous buprénorphine-naloxone, 74 sous clonidine). Les critères d'évaluation du traitemen[...]

Plus d'info

Ajouter à la sélection

Lien externe

Participant characteristics and buprenorphine dose

M. HILLHOUSE ; C. P. CANAMAR ; G. DORAIMANI ; C. THOMAS ; A. HASSON ; W. LING | 2011
Dans American Journal of Drug and Alcohol Abuse (Vol.37, n°5, 2011) Article : Périodique

Background: Clinical parameters for determining buprenorphine dose have not been adequately examined in treatment outcome research. Objectives: This study is a secondary analysis of data collected in a recently completed comparison of buprenorph[...]

Plus d'info

Ajouter à la sélection

Lien externe

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

Y. I. HSER ; A. J. SAXON ; D. HUANG ; A. HASSON ; C. THOMAS ; M. HILLHOUSE ; P. JACOBS ; C. TERUYA ; P. McLAUGHLIN ; K. WIEST ; A. COHEN ; W. LING | 2014
Dans Addiction (Vol.109, n°1, January 2014) Article : Périodique

Aims: To examine patient and medication characteristics associated with retention and continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) treatment for opioid dependence. Design, settings and participants: This s[...]

Plus d'info

Ajouter à la sélection

Lien externe